SynthesisDiabetes, obesity & metabolism2016

Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 analogue, in Latino/Hispanic patients with type 2 diabetes: post hoc analysis of data from four phase III trials.

J A Davidson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.